relatlimab,nivolumab
bms
['neopredict', 'lung']
phase 2 trial neopredict lung : combination double immunotherapy anti-pd1 and anti-lag3 is feasible increasing pathological response #asco23 
Born in Majorca. Medical oncologist. Clinical researcher. Focused in lung cancer. World citizen. Major concerns: human inequality and blue planet environment